ACHIEVEMENTS OF THE INTERNATIONAL RARE DISEASES RESEARCH CONSORTIUM AND FUTURE CHALLENGES

来源 :The 2nd International Rare Diseases Research Consortium Conf | 被引量 : 0次 | 上传用户:zhwa
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The International Rare Diseases Research Consortium (IRDiRC) brings together members that share goals and principles,and have agreed to work in a coordinated and collaborative manner within a multinational consortium to advance research in rare diseases.Its over 40 members are public and private research funding organizations and companies from Europe,North America,Asia and Australia,that have each dedicated over 10 million USS to research into rare diseases.
其他文献
With the development of medical genetics,the understanding of genetic disorders changed extremely,from only some rare diseases associated with genetic in the beginning to that almost all of the diseas
会议
The International Mouse Phenotyping Consortium (IMPC) is building the first comprehensive functional catalogue of a mammalian genome,which will give new insights into gene function and human disease.T
会议
Majority of rare endocrine disorders are related to improper functioning of the endocrine glands,including pancreas and the pituitary,thyroid and adrenal glands.Many rare disorders are caused by endoc
会议
Human genetic research has,and continues to,identify genes that cause human disease.This research has paved the way for drug discovery efforts,providing direct human evidence of the role a particular
会议
"Deafness is the most calamitous of human affliction",said physician Samuel Johnson in the eighteenth century.In China,among the largest population in the world,more than 27.8 million people suffered
会议
Rare disease is defined as any disease that affects a small percentage of the population (normally less than 1 in 15,000).But in China,any"rare"diseases have huge patient population,e.g,there are 200,
会议
We have reported clinical exome sequencing results for over 4000 patients,most of which are pediatric patients with neurological manifestations,since October 2011 and have achieved a molecular diagnos
会议
The international Human Genome Project (HGP) has"changed biology and biotech for ever"by cultivating a new culture of COLLABORATION on global research,a new field of GENOMICS followed by trans-omics i
会议
Maternal Immune Activation (MIA) has been highlighted to be a risk factor for neurodevelopmental disorders such as schizophrenia and autism.However,the link between MIA and epigenomic modifications ha
会议
Hirschsprung disease (HSCR) is a congenital birth defect with relatively low prevalence (1 per 5000 live births) in world-wide population.Previous genetic and functional studies reveal HSCR is caused
会议